tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXEL Stock Latest News

Midday Fly By: GM, Coca-Cola report Q3 beats
The FlyMidday Fly By: GM, Coca-Cola report Q3 beats
2d ago
GE
GM
Goldman downgraded, Coinbase initiated: Wall Street’s top analyst calls
PremiumThe Fly
Goldman downgraded, Coinbase initiated: Wall Street’s top analyst calls
2d ago
ES
GS
Exelixis price target lowered to $44 from $50 at Morgan Stanley
PremiumThe Fly
Exelixis price target lowered to $44 from $50 at Morgan Stanley
2d ago
EXEL
Exelixis price target lowered to $30 from $36 at Wells Fargo
PremiumThe Fly
Exelixis price target lowered to $30 from $36 at Wells Fargo
2d ago
EXEL
Leerink upgrades Exelixis to Outperform following ESMO presentation
PremiumThe Fly
Leerink upgrades Exelixis to Outperform following ESMO presentation
2d ago
EXEL
Exelixis upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyExelixis upgraded to Outperform from Market Perform at Leerink
2d ago
EXEL
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
Premium
Ratings
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
3d ago
EXEL
Midday Fly By: AWS hit by outage, Kering sells beauty unit
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
3d ago
BA
DX
Exelixis falls -12.8%
PremiumThe Fly
Exelixis falls -12.8%
3d ago
EXEL
Exelixis falls -12.5%
PremiumThe Fly
Exelixis falls -12.5%
3d ago
EXEL
Morning Movers: Cleveland-Cliffs surges following earnings report
PremiumThe Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
3d ago
CLF
COO
Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
PremiumRatings
Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
3d ago
EXEL
Exelixis reports detailed results from STELLAR-303
PremiumThe FlyExelixis reports detailed results from STELLAR-303
3d ago
EXEL
Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
Premium
The Fly
Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
4d ago
EXEL
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
Premium
Ratings
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
8d ago
EXEL
Exelixis Hold Rating: Modest Sales Forecasts and Competitive Challenges Amid Upcoming STELLAR-303 Data
PremiumRatings
Exelixis Hold Rating: Modest Sales Forecasts and Competitive Challenges Amid Upcoming STELLAR-303 Data
9d ago
EXEL
Optimistic Buy Rating for Exelixis Amid Promising Phase III Trial Results for Zanzalintinib
PremiumRatings
Optimistic Buy Rating for Exelixis Amid Promising Phase III Trial Results for Zanzalintinib
22d ago
EXEL
Novo Nordisk, Grab, Vistra, Exelixis, Dropbox: Trending by Analysts
PremiumWeekend Updates
Novo Nordisk, Grab, Vistra, Exelixis, Dropbox: Trending by Analysts
1M ago
DBX
NVO
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
PremiumThe Fly
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
1M ago
Z
KR
Exelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
PremiumRatingsExelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
1M ago
EXEL
Exelixis price target raised to $50 from $46 at Morgan Stanley
Premium
The Fly
Exelixis price target raised to $50 from $46 at Morgan Stanley
1M ago
EXEL
Exelixis initiated with a Buy at Goldman Sachs
Premium
The Fly
Exelixis initiated with a Buy at Goldman Sachs
1M ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >